Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study - de Valk-de Roo, GW; Stehouwer, CD; Meijer, P (Arterioscler Thromb Vasc Biol, 1999)
et al.